Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug molecule and the target being crucial for reducing drug discovery costs, ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Drug delivery systems often face two critical ... Given the vast range of possible interactions in peptide design, it may be feasible to tailor peptides for specific drugs, extending their ...